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β
-Actin, once thought to be an exclusively cytoplas-
mic protein, is now known to have important func-
tions within the nucleus. Nuclear β-actin associates 
with and functions in chromatin remodeling complexes, 
ribonucleic acid polymerase complexes, and at least some 
ribonucleoproteins. Proteins involved in regulating actin 
polymerization are also found in the interphase nucleus. 
We deﬁ  ne the dynamic properties of nuclear actin mole-
cules using ﬂ  uorescence recovery after photobleaching. 
Our results indicate that actin and actin-containing com-
plexes are reduced in their mobility through the nucleo-
plasm diffusing at  0.5 μm
2 s
−1. We also observed that 
 20% of the total nuclear actin pool has properties of 
polymeric actin that turns over rapidly. This pool could be 
detected in endogenous nuclear actin by using ﬂ  uorescent 
polymeric actin binding proteins and was sensitive to 
drugs that alter actin polymerization. Our results validate 
previous reports of polymeric forms of nuclear actin ob-
served in ﬁ  xed specimens and reveal that these polymeric 
forms are very dynamic.
Introduction
Several recent studies have demonstrated that the cytoskeletal 
protein actin has important functions within the nucleoplasm 
(Olave et al., 2002; Pederson and Aebi, 2002; Goldman, 2003). 
The fi  rst  identifi   ed function that unambiguously required a 
  nuclear pool of nonmuscle actin was chromatin remodeling. 
β-Actin and a series of recently discovered actin-related proteins 
have been characterized both biochemically and genetically as 
components of chromatin remodeling complexes (Olave et al., 
2002). The role of actin in the nucleus is not limited to chromatin 
remodeling. β-Actin was recently found to bind specifi  cally to 
hrp65-2; blocking this interaction in vivo resulted in a dramatic 
reduction in RNA polymerase II transcription (Percipalle et al., 
2003). β-Actin also resides as a component of the Balbiani ring 
gene messenger RNP (mRNP) throughout its nuclear maturation 
and export to the cytoplasm (Percipalle et al., 2001). These com-
plexes appear to require β-actin in its monomeric form. More 
recently, studies have shown that actin is associated with and re-
quired for transcription by RNA polymerase I (Fomproix and 
Percipalle, 2004; Philimonenko et al., 2004), II (Hofmann et al., 
2004; Kukalev et al., 2005), and III (Hu et al., 2004).
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The cellular concentration of actin is typically at least 
100–1,000 times higher than the concentration required for ac-
tin to spontaneously polymerize in vitro (Pollard et al., 2000). 
The concentration of nuclear actin is therefore suffi  cient to 
spontaneously polymerize and will require active processes to 
prevent polymerization. Indeed, several critical regulators of ac-
tin polymerization can be found in the nucleoplasm. For exam-
ple, phosphoinositide signaling occurs within the nucleus and 
is initiated by a nucleus-specifi  c isoform of phospholipase C 
(Irvine, 2003). The machinery for phosphoinositide signaling is 
enriched in splicing factor compartments (Boronenkov et al., 
1998; Didichenko and Thelen, 2001; Tabellini et al., 2003). 
Much of the nuclear monomeric actin pool has recently been 
reported to be bound in a complex with actin depolymerizing 
factor/cofi  lin (Chhabra and dos Remedios, 2005). Other  proteins 
that sequester monomers of actin (Huff et al., 2004), cap fi  la-
ments (Van Impe et al., 2003; De Corte et al., 2004), or are 
  directly involved in regulating the polymeric state of actin 
  (Vetterkind et al., 2002; Mizutani et al., 2004; Archer et al., 
2005) are   present in the nuclei. The regulation of nuclear actin 
is therefore likely to include the controlled polymerization and 
depolymerization of actin and involve both mechanisms that 
stimulate polymerization, such as phosphoinositides, and 
  molecules that inhibit actin polymerization or regulate the size 
of actin polymers.JCB • VOLUME 172 • NUMBER 4 • 2006  542
Specifi  c affi  nity reagents for globular species of actin and 
fi  lamentous species of actin have been used to detect nuclear 
actin and nuclear actin fi  laments (Nakayasu and Ueda, 1983; 
Lachapelle and Aldrich, 1988; Kushnaryov et al., 1990; Mila-
nkov and De Boni, 1993; Amankwah and De Boni, 1994; Sau-
man and Berry, 1994; Gonsior et al., 1999; Percipalle et al., 
2001; Okorokov et al., 2002; Zhang et al., 2002; Kiseleva et al., 
2004). Unfortunately, the conclusions of these studies are com-
plicated by the fact that the different reagents used in these stud-
ies lead to different results and different conclusions on 
localization and polymerization state of the nuclear actin pool. 
Consequently, current models of nuclear actin function are 
speculative, with most discussions on the subject proposing that 
nuclear actin exists and functions as a monomer (Boyer and 
  Peterson, 2000) or as short oligomers (Olave et al., 2002; Gold-
man, 2003; Percipalle et al., 2003).
In this study, we take the fi  rst step toward quantifying the 
properties of actin within the living nucleus. Using fl  uorescently 
tagged actins and actin binding proteins, we measured the steady-
state distribution and dynamics of nuclear actin in living HeLa 
cells. In fl  uorescence recovery after photobleaching (FRAP) ex-
periments, nuclear actin, like cytoplasmic actin, presented as 
both rapidly and slowly moving kinetic populations. Based on 
the loss of this slow moving population when cells are treated 
with latrunculin and the absence of this population when a mu-
tant actin incapable of polymerization is used in place of wild-
type β-actin, we conclude that this slow recovering population is 
comprised of polymeric (F) actin. Thus, rather than polymeriza-
tion, the only signifi  cant difference between the pools of cyto-
plasmic and nuclear actin is the bundling of cytoplasmic actin 
that generates the stress fi  bers that are prominent in cells stained 
with fl  uorescent phalloidin. Under normal physiological condi-
tions, actin bundles are exclusively found in the cytoplasm.
Results
HeLa cells maintain a dynamic actin 
cytoskeleton in the presence of GFP-actin
The kinetics of actin polymerization and cytoskeletal dynamics 
can be quantifi  ed by microinjection of purifi  ed and fl  uores-
cently tagged β-actin (Miller et al., 1988; McGrath et al., 
1998a,b; Schafer et al., 1998; Albuquerque and Flozak, 2001) 
or by the expression of a GFP-fusion protein (Doyle and Bot-
stein, 1996; Fischer et al., 1998; Verkhusha et al., 1999; Shel-
den et al., 2002). Both fl   uorescent probes have been used 
successfully to estimate the dynamics of actin and F-actin in 
cell types ranging from yeast to mammals (Doyle and Botstein, 
1996; Westphal et al., 1997; Ballestrem et al., 1998; Verkhusha 
et al., 1999; Herget-Rosenthal et al., 2001). Stable expression 
of GFP–β-actin (or spectral variants of GFP fused to actin) has 
been achieved in a wide variety of cell lines with different mo-
tility properties, cytoskeletal organizations, and dynamics of 
cytoskeleton remodeling (Ballestrem et al., 1998; Choidas et al., 
1998; Herget-Rosenthal et al., 2001). Thus, fl  uorescent actins 
are well-established probes for investigating actin dynamics 
in living cells.
Because actin is normally found in the nucleoplasm, it 
stands to reason that fl  uorescent actins can also be used to mea-
sure the dynamic properties of nuclear actin. We fi  rst deter-
mined whether GFP-actin could be detected in suffi  cient 
quantity to allow kinetic measurements in living cells. Fig. 1 
shows a fi  eld of HeLa cells that are stably transfected with 
GFP–β-actin (Fig. 1 A; and Fig. 1, B and C, green). We were 
unable to simultaneously detect GFP–β-actin with endogenous 
β-actin by immunoblotting despite using several independent 
antibody preparations recognizing different epitopes on β-actin. 
Because the protein was readily detected using an anti-GFP an-
tibody, we believe that this is likely due to the low relative abun-
dance of the EGFP-tagged actin relative to the endogenous actin 
pool. It was   necessary to use a separate approach to estimate the 
nuclear actin concentration based on the concentration of dif-
fusing EGFP-actin molecules. Using fl  uorescence correlation 
spectroscopy (FCS), we measured the diffusing pool of EGFP–
β-actin to be present at 0.14 ± 0.11 μM. Measurements of actin 
concentrations in human cell lines (Pollard et al., 2000) indicate 
that the endogenous concentration of actin is at least 1,000 
times higher than that of EGFP-actin.
The drug resistance–based selection of cells for stable ex-
pression reduced the heterogeneity in the expression level of the 
transfected proteins; therefore, stable transfectants were used in 
Figure 1.  Dynamics of GFP-actin in living 
HeLa cells. HeLa cells that stably expressed the 
EGFP–β-actin construct were incubated with 
1 μg/ml of Hoechst 33258 to ﬂ  uorescently stain 
the nuclear chromatin and then imaged live by 
ﬂ  uorescence microscopy. (A) The GFP image 
obtained at the onset of the time-lapse experi-
ment. (B) A composite image where the DNA 
image (red) is superimposed on the GFP-actin 
image (green). The arrows indicate the posi-
tions of F-actin–dependent extensions from the 
cell surface that rapidly remodel throughout 
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most experiments. The nuclei (Fig. 1, B and C, red) are visibly 
depleted in GFP-actin, but actin is nonetheless easily detected 
within the nucleus. Consistent with previous studies, GFP-actin 
was incorporated into a dynamically organized cytoskeleton. 
This was confi  rmed by counterstaining cells with fl  uorescently 
labeled phalloidin (Fig. S1, available at http:// www.jcb.org/cgi/
content/full/jcb.200507101/DC1). Fig. 1 C shows a subregion 
of this fi  eld over time. By examining the cell surface, the dy-
namics of the bundles of fi  laments at the cell surface are eas-
ily illustrated. This time series demonstrates that the GFP-actin 
is incorporated into the expected F-actin–containing structures 
and that these GFP-actin–containing structures can both assem-
ble and disassemble fi  laments that incorporate the GFP-tagged 
actin hybrid protein.
Distribution of GFP–𝗃-actin between 
cellular monomeric and polymeric pools
We employed a commonly used and simple extraction proce-
dure to estimate the effi  ciency of GFP-actin incorporation into 
actin fi  laments and compare it to the effi  ciency of incorporation 
of the endogenous actin within the same cell population. The 
results of this experiment are shown in Fig. 2. The top three im-
ages show the distribution of GFP-actin among soluble (S) and 
fi  lamentous (P) pools isolated from HeLa cells, HeLa cells 
transfected with EGFP, or HeLa cells transfected with EGFP–
β-actin. The bottom two images show the distribution of EGFP–
β-actin and EGFP in the soluble and cytoskeletal fractions. 
When the distribution between soluble and cytoskeletal frac-
tions was quantifi  ed from these immunoblots, the distribution 
for the actin and EGFP actin ranged from 52% of the total pool 
found in the F-actin fraction for EGFP actin to 56% of the total 
pool found in the F-actin fraction for endogenous actin in HeLa 
cells. As expected, EGFP was found entirely within the soluble 
fraction. Stable transfection of EGFP or EGFP–β-actin did not 
signifi  cantly alter the distribution of the endogenous β-actin. 
Collectively, these results demonstrate that EGFP–β-actin is an 
effective probe for β-actin dynamics in vivo. This is consistent 
with the conclusions of previous studies of EGFP–β-actin as a 
probe for actin dynamics in living cells (Pang et al., 1998; 
Verkhusha et al., 1999; Hodgson et al., 2000).
Nuclear extracts support actin 
polymerization
Proteins that bind or sequester actin have been reported to be 
constituents of the nucleoplasm (Pederson and Aebi, 2005). 
Hence, it might be anticipated that the nucleoplasm is rich in 
proteins that regulate actin polymerization. To address this pos-
sibility, we generated nuclear extracts from cells treated for 
60 min with 20 μM latrunculin B and tested the ability of added 
purifi  ed actin to polymerize in vitro. Under these conditions, 
nuclei are released more easily and, as judged by brightfi  eld mi-
croscopy, appear free of cytoplasmic contaminants (unpublished 
data). To control for effects solely due to increased protein con-
centration, purifi  ed actin was incubated with an identical amount 
of BSA. After incubation with either nuclear extract or BSA, 
polymerized actin was separated from soluble actin by centrifu-
gation. Fig. 3 shows the results of an assay with duplicate reac-
tions for each sample. In the presence of BSA, very little actin 
polymerizes under the assay conditions. In contrast, when 
  nuclear extract is mixed with purifi  ed actin, most of the actin 
polymerizes and consequently is found in the pellet fraction.
GFP-actin is homogeneously distributed 
throughout the nucleoplasm
The involvement of the nuclear actin pool in chromatin remod-
eling or transcription/processing of RNAs may result in the 
compartmentalization of the nuclear actin population. Consis-
tent with this hypothesis, there are several reports of the specifi  c 
enrichment of actin within transcription or splicing-associated 
compartments (Milankov and De Boni, 1993; Sahlas et al., 
1993; Nguyen et al., 1998; Gonsior et al., 1999). Because of the 
relative ease in identifying subnuclear domains within the 
mouse embryonic fi  broblast nucleus, we have used this cell line 
to illustrate the subnuclear distribution of β-actin (Fig. 4 A). All 
cell lines examined, including HeLa, showed an identical sub-
nuclear organization. Fig. 4 A illustrates that GFP-actin is ho-
mogeneously distributed throughout the nucleoplasm. Line 
scans were used to quantify actin distribution within the nucleus 
(Fig. 4 A). The nuclear regions of lowest GFP-actin concentra-
tion, the nucleoli, maintain concentrations of actin that are 
 10% of the cytoplasmic concentration (Fig. S4, available 
Figure 2.  Immunoblotting of cytosolic and cytoskeletal cellular fractions. 
HeLa cells were lysed in the presence of Triton X-100 to solubilize the cyto-
sol (S). The polymerized actin remains in the cell pellet (P). HeLa cells, HeLa 
cells stably expressing GFP–β-actin, and HeLa cells stably expressing GFP 
were analyzed using this procedure. The SDS-soluble proteins were then 
electrophoresed on an 8% polyacrylamide–SDS gel, transferred, and de-
veloped using a ﬂ  uorescently tagged antibody. Quantitative immunoblots 
were then collected using an Odyssey system (Li-Cor). The labels on the left 
indicate the types of cells used for the experiment, and the labels on the 
right indicate the antigen recognized by the antibody (Ab) used to develop 
the blot.
Figure 3.  In vitro polymerization of actin in the presence of nuclear 
  extract. Partially polymerized actin was incubated alone, in the presence 
of nuclear extract, or in the presence of BSA. After centrifugation, superna-
tant and pellet fractions were resolved by SDS-PAGE and visualized with 
Coomassie blue. Each reaction was performed in duplicate, and both sam-
ples were loaded onto the gel. S indicates the monomer population, 
whereas P indicates the polymerized population.JCB • VOLUME 172 • NUMBER 4 • 2006  544
at  http://www.jcb.org/cgi/content/full/jcb.200507101/DC1). 
As a control, we demonstrated that an exclusively cytoplasmic 
 fl  uorescently tagged dextran does not show any evidence 
of   nuclear fl  uorescence (Fig. S5 B). Because of the small size 
of the nucleolus, however, it is not possible to rule out the 
  possibility that the source of the nucleolar signal originates in 
the nucleoplasm.
We confi  rmed that the failure to enrich in specifi  c subnu-
clear domains was not solely a property of the GFP-tagged ver-
sion of β-actin. Fig. 4 B shows the distribution of rhodamine 
actin in living HeLa cells. Like GFP-actin, rhodamine actin is 
present in signifi  cant quantities in the nucleus and is homoge-
neously distributed outside of the nucleoli (Fig. 4 B; examples 
of nucleoli are illustrated with asterisks).
FRAP measurements of cytoplasmic 
and nuclear F-actin pools
The generation of subnuclear patterns of molecular distribution 
refl  ects both molecular exclusion events (Gorisch et al., 2003) 
and binding interactions (Phair and Misteli, 2001). Binding 
interactions, if they occur with molecules that are much more 
massive than the free protein, will reduce the mobility of a pro-
tein through the local environment. If these binding sites are of 
suffi  cient affi  nity and spatial density, the concentration of the 
protein within the local environments that contain binding sites 
will be higher at steady state than the concentration that is un-
bound and diffusing through the nucleoplasm. When the spatial 
information obtained from live cell imaging is combined with 
kinetic information on the underlying molecular fl  ux, it becomes 
possible to investigate the relationships between organization 
and function in a quantitative manner. Therefore, we examined 
the mobility properties of actin within the nucleoplasm of living 
cells to determine whether kinetic populations of actin could be 
resolved that may differ functionally.
The molecular fl  ux of actin has been studied in the living 
cytoplasm. These experiments, which used microinjection of 
fl  uorescently labeled β-actin, easily resolved monomeric and 
polymeric pools of actin (Amato and Taylor, 1986; McGrath 
et al., 1998a; Star et al., 2002). This is expected when the cyto-
plasm is measured because the actin becomes incorporated into 
fi  laments that are suffi  ciently large that the rate of fi  lament turn-
over, rather than diffusion, limits the rate of fl  uorescence recov-
ery in these studies. We confi  rmed that the cytoplasmic pool 
resolved into two distinct populations during recovery from 
photobleaching of GFP–β-actin in living HeLa cells. When the 
recovery profi  les from many individual cells are pooled and the 
mean kinetic properties of the cytoplasmic actin pool are com-
pared with the nuclear pool, the recovery profi  les are very simi-
lar (Fig. 5). The x axis (time) is plotted on a log scale to better 
illustrate both the fast and slow phases of the recovery profi  le. 
Figure 4.  The distribution of GFP-actin in the 
living nucleus. (A) Mouse cells (left) or HeLa 
cells (right) stably expressing GFP–β-actin were 
examined by laser-scanning confocal micros-
copy. The lines drawn across the cells indicate 
the path of a 3-pixel-wide linescan, and the ar-
rowhead indicates the direction of the lines-
can. The linescan is shown as pixel number 
versus intensity as a percentage of the maxi-
mum value obtained in the linescan. (B) Rhoda-
mine-conjugated  β-actin was microinjected 
into living HeLa cells. After equilibration of the 
microinjected ﬂ  uorescent actin throughout the 
cell volume, laser-scanning confocal images 
were collected. (left) An image obtained from 
the uppermost surface of a group of microin-
jected HeLa cells. (right) An image obtained 
near the midplane of most of the cell nuclei. 
The asterisks show the position of the nucleoli. 
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Like the cytoplasm, the nucleoplasm clearly resolves into at 
least two distinct kinetic pools. The principal difference be-
tween the recovery kinetics of β-actin in the cytoplasm and 
the recovery kinetics in the nucleus is a small difference in the 
distribution between the fast and slow recovering species. This 
is most evident near the 10-s mark, at which time the rapid re-
covery phase has reached equilibrium. At this point, 84% of the 
nucleoplasmic signal has equilibrated, whereas only 76% of the 
cytoplasmic pool has equilibrated. This difference was statisti-
cally signifi  cant (P < 0.02).
FRAP of EGFP nuclear actin under 
conditions that alter cellular polymeric 
actin pools
In the cytoplasm, the slow phase of the recovery profi  le is gen-
erated by the relatively slow turnover of fl  uorescence within the 
F-actin pool relative to the diffusion rate of the much larger dif-
fusing pool (McGrath et al., 1998a,b).To determine whether the 
slow recovering phase of nucleoplasmic actin is rate limited by 
the turnover of actin fi  laments, we pretreated cells with latrun-
culin A, which depletes the cellular F-actin pool, and then ana-
lyzed the FRAP recovery kinetics. Fig. 6 shows a comparison 
between the recovery of GFP-actin in control cells and in cells 
treated for 1 h with latrunculin A. Latrunculin A completely 
eliminates the slow recovery phase that is otherwise found in 
the nucleoplasmic actin FRAP profi  le (Fig. 6 A; Table I). A sec-
ond drug, swinholide, which can fragment existing polymeric 
actin, also resulted in the loss of the slow recovering fraction of 
nuclear GFP-actin (unpublished data). In contrast, a third drug, 
jasplakinolide, stabilizes actin polymers, and treatment with 
this drug resulted in a time-dependent decrease in the recover-
ing fraction of nuclear actin (Fig. 6 B).
Latrunculin, by destabilizing stress fi   bers, causes the 
treated cells to detach from the coverslip and adopt a more 
spherical morphology. To rule out the possibility that changes in 
cell shape either directly or indirectly alter the mobility of nu-
cleoplasmic actin independent of any direct effects of nuclear 
actin, we also examined the FRAP recovery profi  le of nuclear 
actin in cells that have been pretreated with EDTA. EDTA treat-
ment caused the cells to adopt a rounded shape similar to that of 
the latrunculin-treated cells. However, unlike the latrunculin-
treated cells, the recovery profi  le of nuclear actin in cells de-
tached by EDTA treatment is indistinguishable from that of the 
adherent control cells (Fig. 6 A).
We devised several approaches to confi  rm the presence of 
a nuclear pool of polymerized actin. Fluorescently labeled phal-
loidin was initially used but was found to be unsuitable because 
the binding was reversible when it was studied by FRAP after 
fi   xation with paraformaldehyde. Table I shows the different 
probes used and the proportion of fl  uorescence signal that has 
recovered by 11.5 s into the recovery curve. This time point rep-
resents a period suffi  cient to allow recovery of freely diffusing 
molecules but insuffi  cient time for signifi  cant amounts of the 
slow recovering molecules to equilibrate. As such, where fl  uo-
rescent actins are used, this point represents a good approxima-
tion of the size of the pool of unpolymerized actin. The probes 
were chosen to either incorporate into (FITC- and EGFP-actin) 
or bind to (FITC–anti-actin antibody and moesin-GFP; Edwards 
et al., 1997) F-actin. The subcellular distribution of these probes 
is illustrated in Fig. S5 A. In each case, a slow recovering popu-
lation of nuclear actin was detected and, where tested, was lost 
or reduced upon treatment with latrunculin. The diffusion of the 
fl  uorescent anti–rabbit IgG antibody serves as a   useful control 
for latrunculin-dependent changes that may indirectly alter dif-
fusion in the nucleoplasm. There was no signifi  cant difference 
in the diffusion of microinjected anti–rabbit IgG antibody in the 
presence or absence of latrunculin treatment (Table I).
GFP-actin must be polymerization 
competent to incorporate into the slowly 
recovering nuclear fraction
To directly test the requirement for polymerization in defi  ning 
the low-mobility pool of nuclear actin, we made use of a previ-
ously characterized R62D mutant of actin (Posern et al., 2002). 
This mutant actin does not incorporate into actin fi  laments. We 
prepared an EGFP fusion of the R62D mutant of actin and 
transfected cells with either the R62D variant or wild-type fu-
sion proteins. This EGFP fusion protein was not evident in any 
of the more prominent components of the actin cytoskeleton 
(stress fi  bers and cell cortex). Because the expression of this 
protein altered cellular morphology, we chose to examine the 
kinetics of the mutant protein in transiently transfected cells. 
Fig. 7 shows time-lapse images of transiently transfected GFP–
β-actin (top) and GFP–R62D–β-actin (bottom) collected dur-
ing the fi  rst few seconds of the recovery phase. The differences 
between the two proteins are most evident at these earliest 
stages of the recovery period. The fi  rst image of each time lapse 
shows the cell before photobleaching a 2-μm-wide line across 
the cell nucleus. The differences in the mobility of the two pro-
teins are obvious in the fi  rst image collected after photobleaching. 
In the wild-type GFP-actin images, the photobleached region is 
Figure 5.  Recovery of GFP-actin in the cytoplasmic and nuclear compartments. 
HeLa cells stably expressing GFP–β-actin were analyzed by FRAP. FRAP 
data was collected from cells where either the cytoplasm or the nucleo-
plasm was photobleached. The mean recovery proﬁ  le is plotted versus re-
covery time. Time is plotted on a log scale to better illustrate both the rapid 
and the slow populations of molecules.JCB • VOLUME 172 • NUMBER 4 • 2006  546
obvious, whereas in the R62D mutant GFP-actin, inhomogene-
ity is evident but there is no clearly defined photobleached 
region. The absence of a clear photobleached region refl  ects 
the rapid mobility of the protein being examined. The graph in 
Fig. 6 shows the mean recovery profiles of HeLa cells tran-
siently transfected with GFP-actin or R62D mutant GFP-actin. 
For comparison, the recovery profi  le of GFP-actin obtained 
from cells treated with latrunculin is also plotted.
Dynamic properties of nuclear 
polymeric actin
We analyzed the data using mathematical models to simulate 
two possible mechanisms for explaining the recovery profi  le of 
nuclear β-actin. The development of the mathematical simula-
tions of nuclear GFP-actin and the fi  tting of these models to 
the experimental data has been published separately (Carrero 
et al., 2004a,b). In simple terms, we assumed that the recovery 
curve refl  ected a mixture of rapidly diffusing complexes con-
taining one or a few actin molecules and much slower mov-
ing polymeric actin species. In this model, both species recover 
through diffusion of new fl  uorescently labeled macromolecules 
or polymers into the region that has undergone photobleaching. 
The second model assumes that although polymeric actin may 
diffuse, its rate of diffusion is slower than the rate of remod-
eling of the polymer with new fl  uorescent monomers through 
treadmilling of actin polymers. In this case, the fi  rst phase of the 
recovery curve refl  ects diffusion of actin monomers and com-
plexes, whereas the second phase of the recovery curve repre-
sents the turnover time of monomers within larger polymeric 
actin structures. Both mathematical simulations produced a very 
good approximation of the experimental data (Carrero et al., 
2004a), demonstrating that either a turnover process or a diffu-
sion-dependent process can explain the observed recovery rates. 
The effective diffusion coeffi  cients for the fast phase and the 
slow phase were estimated at 0.47 μm
2 s
−1 and 0.009 μm
2 s
−1, 
respectively. The measured rate of diffusion obtained by FCS, 
 30 μm
2 s
−1 is more consistent with the expected diffusion 
rate of a protein of this size. In vitro, the measured rate of actin 
monomer diffusion is  70 μm
2 s
−1 (Lanni and Ware, 1984). 
Thus, even this fast phase migrates at least 50 times slower than 
expected for a molecule of monomeric size diffusing through 
the nucleoplasm.
If we simulate the recovery of the slow phase as a refl  ec-
tion of the underlying kinetics of actin polymerization and de-
polymerization, the data can be fi  t by a population consisting 
of 84% of the nuclear β-actin molecules residing in the G-actin 
pool, whereas the remaining 16% are incorporated into actin fi  l-
aments for a mean duration of 76 s (Carrero et al., 2004a). Poly-
meric actin found within the cytoplasm is known to be dynamic 
and show different turnover rates in different regions of the cell. 
Figure 6.  Recovery of nuclear actin in the 
presence and absence of an inhibitor of actin 
polymerization. The recovery kinetics of GFP-
actin was quantiﬁ  ed in stably transfected HeLa 
cells, HeLa cells that were treated with latrun-
culin A, and HeLa cells that were treated with 
EDTA. The relative intensity is plotted versus 
time, with time plotted on a log scale.
Table I. FRAP recovery of ﬂ  uorescent actins and ﬂ  uorescent actin binding proteins
Protein Latrunculin Percentage recovery Standard deviation P-value
Moesin-GFP − 91.3 4.7
+ 97.2 3.5 ≤0.001
Anti-actin antibody − 78.5 4.8
+ 85.9 4.9 ≤0.001
Anti–rabbit IgG − 94.2 1.8
+ 93.5 1.3 NS
GFP-actin (transient) − 84.7 4.5
+ 97.8 2.5 ≤0.001
R62D actin–GFP − 99.3 1.4
GFP-actin (stable) − 84.0 9.4
FITC actin − 90.3 4.9
Percentage of recovery was measured at 11.5 s after photobleaching for each protein examined. In some instances, cells were preincubated for 60 min with latrunculin A. 
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For example, actin cables, which represent bundles of actin mi-
crofi  laments, require several minutes to turn over their constitu-
ent actin monomers and represent relatively stable polymeric 
actin structures (Kreis et al., 1982; Wang, 1987). In contrast, 
the polymeric actin assembled at the leading edge of the cell 
turnover with half-lives of <30 s (Amato and Taylor, 1986; Star 
et al., 2002). The rate of actin turnover in the nucleus is  relatively 
high but similar to what is observed for polymeric actin outside 
of actin cables (Amato and Taylor, 1986; McGrath et al., 1998b; 
Theriot and Mitchison, 1991; Sund and Axelrod, 2000).
Identiﬁ  cation of multiple diffusing species 
of GFP-actin in the nucleus of living cells
To further assess the properties of the diffusing forms of GFP-
  actin within the nucleoplasm, we used FCS. FCS is a technique 
that measures stochastic fl  uctuations in the fl  uorescence emission 
that corresponds to molecules moving into and out of the focal 
point of the objective lens. Because the focal plane has a defi  ned 
volume, this information can be directly used to quantify the dif-
fusion rate of the fl  uorescent species through the focal volume. 
In principal, current mathematical modeling of FCS data enables 
no more than three diffusing components to be estimated. When 
the nucleoplasm and the cytoplasm were simultaneously mea-
sured by FCS, the diffusing species resolve into roughly four sep-
arate effective diffusion rates (Fig. S2, available at http://www.jcb.
org/cgi/content/full/jcb.200507101/DC1). Approximately 70% of 
both the nuclear and the cytoplasmic actin pools diffuse at a rate 
of  30 μm
2 s
−1, consistent with the diffusion of monomeric actin 
or small complexes containing actin. The remainder of the de-
tected GFP-actin–containing molecules diffuse at rates that are 
between 10 and 500 times slower than the monomeric pool.
The relationship between actin 
polymerization and RNA 
polymerase II transcription
There is now evidence that actin is a required component of the 
RNA polymerase holoenzymes (Hofmann et al., 2004; Hu et al., 
2004; Philimonenko et al., 2004). Based on this association, it is 
possible that the regulation of actin polymerization and nuclear 
transcription are interdependent. To address this possibility, 
we fi  rst determined whether inhibiting transcription altered the 
kinetic properties of the nuclear actin pools. Inhibition of RNA 
polymerase I transcription using actinomycin D or RNA poly-
merase II using 5,6-dichloro-1-β-d-ribofuranosylbenzimidazole 
(DRB) yielded similar results. Fig. 8 shows the FRAP recovery 
curves of nuclear actin after 4 h of pretreatment with the RNA 
polymerase II transcriptional inhibitor DRB relative to the FRAP 
recovery curves of nuclear actin under normal growth conditions 
or when cells are pretreated with latrunculin B. These results 
demonstrate that there is a similar equilibrium between poly-
meric and monomeric actin, regardless of whether transcription 
is occurring. We next examined whether depolymerization of 
cellular polymeric actin altered transcription rates. In this exper-
iment, a signifi  cant effect was seen. Mouse 10T1/2 cells were 
the most sensitive of the cell lines tested. Upon treatment with 
latrunculin, the incorporation of [
3H]uridine into nuclear RNA 
was inhibited by >90%. This was also evident in experiments 
incorporating 5-fl  uorouridine into nascent RNA, but analysis 
by indirect immunofl  uorescence is complicated by rounding 
and detachment of cells (unpublished data). A B cell line (Raji)   
was also examined for 5-fl  uorouridine incorporation in nascent 
RNA. These cells grow in suspension and do not contain the 
extensive cytoskeleton present in adherent cell lines. When Raji 
cells were analyzed by fl  ow cytometry for the incorporation of 
5-fl  uorouridine into nascent RNA, although less sensitive than 
the mouse embryonic fi  broblasts, we also observed signifi  cant 
inhibition after treatment with latrunculin  (Fig. 9).
The inhibition of transcription by the actin binding drug 
latrunculin could be due to the drug interfering with the associa-
tion of actin monomers with the RNA polymerase complexes. 
To determine whether this was the mechanism responsible for 
the inhibition of transcription that we observed, we performed 
Figure 7.  Recovery of an actin mutant unable to incorporate into ﬁ  laments. 
Photobleaching experiment performed using cells transiently transfected 
with wild type GFP-actin (WT) or actin containing a point mutation at 
amino acid 62 (R62D). From left to right, the images represent prebleach, 
1.5 s postbleach, 5 s postbleach, and 10 s postbleach. Dark colors repre-
sent lower concentrations of GFP, whereas bright colors represent higher 
concentrations, with white being the most concentrated. The bottom panel 
shows the FRAP recovery proﬁ  les of GFP-actin, GFP-actin + latrunculin, 
and the R62D actin mutant.
Figure 8.  FRAP recovery curve of EGFP–𝗃-actin in the presence of tran-
scriptional inhibitors. The recovery kinetics of GFP-actin was quantiﬁ  ed in 
stably transfected HeLa cells and HeLa cells that were treated with the 
RNA polymerase II transcription inhibitor, DRB, for 4 h before performing 
the FRAP experiment. The results obtained with latrunculin B are shown 
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coimmunoprecipitation experiments. We observed that an anti-
body directed against β-actin coimmunoprecipitates RNA poly-
merase II independent of whether the cell extracts were obtained 
from latrunculin-treated or control cells (Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200507101/DC1).
Discussion
In this study, we sought to defi  ne the kinetic properties of the 
nuclear actin pool in living cells. Our results demonstrate that 
nuclear actin exists in several different kinetic populations, in-
cluding a signifi  cant pool of polymeric actin. The effective 
 diffusion  coeffi  cient of the rapidly recovering pool of nuclear 
actin was  0.5 μm
2 s
−1. This mobility is  50–100 times slower 
than expected of actin monomers or multimolecular complexes 
incorporating actin and could contain some oligomeric com-
plexes of actin. When translated into mass equivalents, this rep-
resents up to a 1,000,000-fold increase in mass that is required 
to explain the reduced diffusion of the rapidly recovering popu-
lation of actin molecules. It is more reasonable to explain differ-
ences of this magnitude based on binding interactions (Phair 
and Misteli, 2001; Carrero et al., 2004b; Phair et al., 2004). In 
this respect, it is notable that the rate of effective diffusion is 
similar to what is observed for many chromatin binding pro-
teins, including those that modify chromatin structure (Phair 
et al., 2004). Thus, the diffusion of monomers or oligomers that 
are incorporated into protein complexes as well as the reversible 
binding interactions that these complexes undergo in the nu-
cleoplasm are likely to all contribute to the fast phase of actin 
recovery observed during FRAP.
The more slowly recovering population of nuclear actin 
was directly correlated with the ability of actin to polymerize 
and was also detected among endogenous actin pools when 
photobleaching experiments were performed on fl  uorescent 
proteins that specifi  cally bind actin in the F-actin state. We 
found that the equilibrium between the monomer and polymer 
state differs only slightly between the nucleus and the cyto-
plasm. The nuclear pool of polymeric actin turns over slightly 
faster than what is observed in the cytoplasm. In addition, the 
nucleoplasm contained a slightly lower proportion of polymeric 
actin than the cytoplasm.
Based on the geometry of the interchromatin space, 
  Pederson and Aebi (2002) have suggested that it is unlikely that 
long fi  laments of actin exist in the nucleoplasm. Others have 
speculated that oligomeric actin may associate with the nuclear 
lamina and/or RNA polymerase II transcription sites  (Goldman, 
2003; Fomproix and Percipalle, 2004). The slow recovering 
phase containing the polymeric fraction of nuclear actin could 
be explained by more than one potential mechanism. First, 
oligomeric actin or relatively small actin polymers could be 
complexed with larger structures within the nucleoplasm. 
In this case, polymers could be relatively small and yet essen-
tially immobile within the nucleoplasm. Alternatively, the mass 
of the polymer, either as a fi  lament or as a network of fi  laments, 
may be too large to diffuse through the nucleoplasm whether or 
not it binds to other nuclear structures. Given that the concen-
tration of cellular actin is hundreds to thousands of times 
greater than the critical concentration for spontaneous poly-
merization of actin, even if there were a 10-fold reduction in 
the concentration of actin within the nucleoplasm, it would still 
far exceed what could be maintained in a monomeric form 
without regulation.
Although the FRAP recovery curve of nuclear actin re-
vealed that  20% of the nuclear actin pool recovered with the 
kinetics of a polymeric actin pool, we wanted to verify that 
this fraction contained polymeric actin. The conclusion that 
this pool is predominantly or entirely polymeric actin is sup-
ported by the following observations: (a) the detection of the 
slow migrating population using fl  uorescently tagged actin, 
Figure 9.  Transcriptional activity in the presence of latrunculin. (A) The 
immunoﬂ  uorescence images show 5-ﬂ  uorouridine incorporation (left and 
right, green) in mouse 10T1/2 cells without (top) or with (bottom) pretreat-
ment for 60 min with latrunculin. The corresponding color composite im-
ages show 5-ﬂ  uorouridine (green), DAPI (red), and Alexa 546 phalloidin 
(blue). (B) Flow cytometry proﬁ  les of cells treated with DRB and actinomycin D 
(red line), 0.2 mM latrunculin B (blue line), or 0.05 mM latrunculin B (green 
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regardless of the fl  uorescent tag used or the method of intro-
duction into the cell; (b) the detection of this same pool of 
slow migrating actin when fl  uorescent probes that bind specifi  -
cally to endogenous actin or F-actin are used; (c) the loss of 
this population, independent of whether actin is fl  uorescently 
tagged or a fl  uorescent tag is present on an actin binding pro-
tein, when cells are incubated with latrunculin; (d) the failure 
to detect this slow phase of nuclear actin when an actin mutant 
that does not incorporate into fi  laments is measured using 
FRAP; and (e) the stabilization of this fraction in cells treated 
with jasplakinolide.
One of the principal mechanisms for initiating actin poly-
merization in the cytoplasm is through phosphoinositide release 
and the generation of phosphatidylinositol-4,5-  bisphosphate; 
thus, the cell membrane is where much of the cytoplasmic 
actin polymerization is initiated (Yin and Janmey, 2003). 
Although the nuclear membrane may similarly function as a 
site where actin polymerization is initiated (Shumaker et al., 
2003; Gruenbaum et al., 2005; Wilson et al., 2005), the nu-
clear phosphoinositide signaling machinery and nuclear phos-
phoinositides colocalize with splicing factor compartments 
(Boronenkov et al., 1998; Didichenko and Thelen, 2001) and 
thereby provide a potential site to nucleate actin polymeriza-
tion distant from the nuclear membrane. Because these sites 
are centrally located within the euchromatic domains of the 
nucleus, these sites are well positioned to regulate the poly-
merization of actin throughout the nucleoplasm. With the ex-
ception of depletion in the nucleolus, we did not fi  nd evidence 
of signifi  cant inhomogeneities in the presence of either diffus-
ing or polymeric and immobilized nuclear actin analogous to 
what are observed for proteins that enrich in splicing factor 
compartments or other nuclear bodies. Although this result is 
consistent with an essentially homogeneous distribution of ac-
tin and polymeric actin outside of the nucleolus, the large size 
of the monomer pool may require large differences in nucleo-
plasmic concentrations of polymeric actin to be evident using 
this approach.
When actin was depolymerized with latrunculin, we ob-
served a signifi  cant, although not complete, inhibition of tran-
scription. β-Actin has recently been found to directly associate 
with both RNA polymerase I and II holoenzymes and is re-
quired for transcription in vitro (Percipalle et al., 2003; Fom-
proix and Percipalle, 2004; Philimonenko et al., 2004; Kukalev 
et al., 2005). Although our result is consistent with a function of 
F-actin in the transcription process, until better tools are devel-
oped for specifi  cally targeting nuclear polymeric actin without 
altering the cytoplasmic fraction, the experiment cannot be 
 considered  conclusive.
In summary, our results demonstrate that actin polymer-
ization occurs within the living nucleoplasm and highlight the 
necessity to consider monomeric, oligomeric, or polymeric 
forms of actin as studies continue to reveal new functions and 
nuclear complexes that contain actin. To make signifi  cant prog-
ress in discriminating between these possibilities, it is essential 
that methods be developed that selectively target the state of 
  polymerization within the nucleus without directly altering 
  polymerization within the cytoplasm.
Materials and methods
Generation of cells stably expressing GFP-actin
Human  β-actin containing an NH2-terminal EGFP was purchased from 
CLONTECH Laboratories, Inc. Indian muntjac ﬁ  broblast, mouse 10T1/2, 
HeLa, and SK-N-SH human neuroblastoma cells were each transfected with 
the GFP-actin construct, and stable expression of the plasmid was selected 
for using G418. In some instances, drug-resistant cultures were further 
  selected by ﬂ  uorescence-activated cell sorting for GFP expression. R62D 
actin was provided by R. Treisman (Cancer Research UK, London, UK), and 
moesin-GFP was provided by D. Kiehart (Duke University, Durham, NC).
FRAP
Our protocol for FRAP has been described in detail previously (Lever et al., 
2000). In brief, living cells were photobleached in 2-μm-diameter circles or 
1.5-μm strips (for mathematical modeling) across the width of the nucleus 
using a laser-scanning confocal microscope (LSM 510; Carl Zeiss MicroIm-
aging, Inc.) and a 488-nm laser line at 100% intensity for 20 iterations. 
Photobleaching was completed in <250 ms. The recovery of the ﬂ  uores-
cence signal over time was then monitored and used to measure the mobil-
ity of the actin. Because the stress ﬁ  bers are the brightest GFP-actin–containing 
structures within the cells, it was necessary to close the pinhole aperture on 
the LSM 510 to the extent that light was collected from sections no thicker 
than 2 μm. Quantiﬁ  cation of data was not performed on mouse 10T1/2 
or Indian muntjac ﬁ  broblasts because the ﬂ  at proﬁ  le of these cells made it 
difﬁ  cult to exclude the possibility that some of the ﬂ  uorescence was contrib-
uted by stress ﬁ  laments located above or below the nucleus. It was also 
necessary, in some instances, to perform image summing or frame averag-
ing to improve the signal-to-noise ratio and maximize the dynamic range 
during data collection. Finally, the number of scans during collection was 
optimized by increasing the time interval between scans from <1 to 5 s af-
ter the ﬁ  rst 5–10 s of recovery. Recovery curves were generated from be-
tween 20 and 30 individual cells recorded from at least three separate 
experiments. P-values were determined using the t test.
For quantiﬁ   cation, each image was normalized for total ﬂ  uores-
cence intensity relative to the ﬁ  rst image collected after photobleaching to 
correct for any photobleaching that occurred during the collection of the 
postbleach time series. This was accomplished by measuring the total cel-
lular ﬂ  uorescence at each time point. Mathematical modeling of mobility 
using the compartment model (Carrero et al., 2004a,b) used a 2-μm-wide 
line photobleached across the width of the cell nucleus and extended the 
duration of the experiment to  2 min.
Fluorescence microscopy
Images were collected using MetaMorph (Universal Imaging Corp.) 
to control an Axiovert 200 M (Carl Zeiss MicroImaging, Inc.) equipped 
and acquired with a 12-bit charge-coupled device camera (Sensicam; 
Cooke Corp.) or a 14-bit charge-coupled device camera (Cascade; Pho-
tometrics). In some cases, confocal sections were acquired using a laser-
scanning confocal microscope and a pinhole aperture setting of 1 Airy 
unit. GFP was excited using a Xenon lamp or a 488-nm laser line. Rho-
damine was excited using a 514-nm laser line. The spatial sampling 
ranged from 0.07 to 0.15 μm per pixel in the xy plane and 0.2 to 0.4 μm 
in the z plane. For images acquired on ﬁ  elds of cells, a 1.3 NA Plan 
Fluor 40× objective (Carl Zeiss MicroImaging, Inc.) was used. For 
higher magniﬁ  cation images, a 1.4 NA Plan Apo 63× objective (Carl 
Zeiss MicroImaging, Inc.) was used. Time-lapse experiments involving 
living cells were typically acquired at 23°C in standard DME with added 
fetal calf serum.
Image processing and ﬁ  gure construction
Images from the LSM 510 were imported into MetaMorph software if it 
was necessary to apply a 3 × 3 median ﬁ  lter to reduce pixel noise in 
the ﬁ  gure images. Otherwise, images were directly exported as 16-bit 
TIFF ﬁ  les and rescaled over an 8-bit data range. In most cases, the back-
ground ﬂ  uorescence of the medium and the base signal from the detec-
tor are minimized to better represent the dynamic range of the data 
content in the image. In some instances, three-dimensional image sets 
were imported into Imaris 4.12 (BitPlane) and three-dimensional image 
sets were generated. In this instance, the image was scaled to map the 
data over the range of the display and the screen capture function in 
Imaris 4.12 was used to capture the image used in the ﬁ  gure. Figures 
were prepared in Photoshop CS (Adobe) for Windows. In general, im-
ages were scaled to span the 8-bit data depth, reducing background in 
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8-bit grayscale or 24-bit RGB color. If necessary, images were interpo-
lated to 300 dpi using Photoshop.
Drug treatments and cell staining
Cells growing in culture, either in culture ﬂ  asks or plated onto glass cover-
slips, were treated with latrunculin A or B (Calbiochem) at the concentra-
tions indicated. No difference was observed between cells treated with 
latrunculin A or B, with the exception that treatment with latrunculin B 
required a 10-fold increase in concentration. This was expected based 
on the known properties of the two latrunculins. Jasplakinolide was used 
at a ﬁ  nal concentration of 1 μM. Alexa 546–conjugated phalloidin was 
used as recommended by the manufacturer (Invitrogen). Fluorouridine 
was used to determine the synthesis of RNA as described previously 
(Bleoo et al., 2001; Boisvert et al., 2001). For these studies, incuba-
tions of between 10 and 20 min were used for RNA labeling, depend-
ing on the rate of incorporation into the cells (which varies between cell 
types). For ﬂ  ow cytometry analysis, cells were ﬁ  xed with 100% metha-
nol. Unless otherwise indicated, all other ﬁ  xations were performed with 
4% paraformaldehyde.
Microinjection of actins and antibodies into HeLa cells
HeLa cells were plated on glass coverslips embedded in 35-mm dishes. 
Micro    capillaries were drawn from 1.0-mm outer diameter aluminosilicate 
ﬁ  laments on a ﬂ  aming/brown micropipette puller (model P-87; Sutter Instru-
ment Co.). They were loaded from the rear with ﬂ  uorescent actin at 0.5 μg/ml 
in 2 mM Tris HCl, pH 8, 0.1 mM ATP, 0.1 mM DTT, and 0.1 mM CaCl2. 
  Injection was attempted in the nucleus, but occasionally the actin appeared 
to go in the cytoplasm. However, when looking at the injected cells under 
ﬂ  uorescent light, the two were indistinguishable. The cells were then incu-
bated in fresh media for 1–2 h before FRAP experiments.
FCS
FCS data was collected with an LSM 510 NLO using a 488-nm excitation 
source and collected with a 40× C-Apochromat 1.2 NA water immersion 
objective (Carl Zeiss MicroImaging, Inc.) and a ConfoCor 2 detector (Carl 
Zeiss MicroImaging, Inc.). Autocorrelation analysis was performed using 
the software provided with the ConfoCor 2 module. Curve ﬁ  tting was per-
formed by comparing the ﬁ  t (r
2 value) for single, two, and three parameter 
ﬁ   ts. The data was summarized and tabulated as described previously 
(Politz et al., 1998).
Actin polymerization assays
The distribution of actin in soluble and insoluble fractions was determined 
as described previously (Posern et al., 2002). Nuclear extracts were pre-
pared as described previously (Andrin and Hendzel, 2004). An Ultrafree-
MC centrifugal ﬁ  lter (10-kD cutoff; Millipore) was used to concentrate the 
nuclear extract approximately ﬁ   vefold and perform a buffer exchange 
back to buffer A. The concentrated extract was precleared by centrifuging 
at 125,000 g for 1 h at 22°C.
Lyophilized nonmuscle actin was resuspended in 5 mM Tris, pH 8, 
0.2 mM CaCl2, 0.2 mM MgCl2, and 0.2 mM ATP at 2 mg/ml and incu-
bated on ice for 30 min. Nonmuscle actin was partially polymerized on ice 
for 60 min by diluting the actin to 1 mg/ml and adding 1 mM ATP, 2 mM 
MgCl2, and 50 mM KCl (all ﬁ  nal concentrations). This solution was then 
used directly in the spin assay.
Nuclear extract from  8 × 10
5 − 1.0 × 10
6 cells was gently 
mixed with 40 μg F-actin and allowed to incubate at room temperature 
for 30 min. As controls, buffer A alone or 8 μg BSA solubilized in buffer A 
was incubated with 40 μg F-actin under the same conditions. The sam-
ples were then centrifuged at 125,000 g for 90 min at 22°C. The super-
natant was removed, and an appropriate amount of 3× concentrated 
SDS sample buffer was added. The pellets were solubilized in 3× con-
centrated SDS sample buffer and heated at 60°C for 15 min. Approxi-
mately one third of the supernatant and pellet from each sample condition 
was then separated by 10% SDS-PAGE and visualized by Coomassie 
blue staining.
Coimmunoprecipitation experiments
HeLa S3 cells were either treated with 20 μM latrunculin B for 60 min 
before extraction or left untreated and used for control extracts. Whole 
cell extracts were prepared using modiﬁ   ed RIPA buffer (50 mM Tris, 
pH 7.4, 1% NP-40, 150 mM NaCl, and 1.0 mM EDTA) for 60 min on 
ice. Insoluble material was removed by centrifugation at 21,000 g for 
10 min. The supernatant was used as the extract for the immunoprecipi-
tation experiments.
Immunoprecipitations were performed as described by Hoffman 
et al. (2004) with minor alterations. In brief, 10 μg anti–β-actin (AC-15) 
antibody were added to precleared, untreated, or latrunculin B–treated 
whole cell extracts (300 μg diluted 10-fold in 10 mM Tris-HCl, pH 7.9, 
20 mM Hepes, pH 7.9, 8% glycerol, 45 mM KCl, 8 mM MgCl2, 5 mM 
(NH4)2SO4, 2% polyethylene glycol, 4.5 mM β-mercaptoethanol, 0.05 mM 
EDTA, and 0.025% sodium lauryl sarcrosine) and incubated for 2 h at 
4°C. Protein G–Sepharose (150 μl of a 50% solution; GE Healthcare) 
was added, and the mixture was incubated for an additional 2 h at 4°C. 
The beads were washed ﬁ  ve times with ﬁ  ve volumes of IP dilution buffer. 
Bound proteins were recovered by boiling the washed beads in SDS 
sample buffer. The eluted proteins were separated by 10% SDS-PAGE 
and analyzed by protein immunoblotting using antibodies to RNA poly-
merase II or β-actin.
Mathematical modeling of FRAP recovery curves
For mathematical modeling of FRAP recovery curves, see Carrero et al. 
(2004a,b).
Online supplemental material
Fig. S1 shows costaining of cells expressing GFP-tagged β-actin with phal-
loidin. Fig. S2 shows an FCS analysis of GFP-tagged β-actin. Fig. S3 shows 
that RNA polymerase II coimmunoprecipitates with β-actin in the pres-
ence and absence of latrunculin. Fig. S4 shows a series of laser-scanning 
confocal optical sections through cells expressing EGFP–β-actin. Fig. S5 
shows ﬂ   uorescence microscopy of indirect actin probes and ﬂ  uorescent 
dextrans. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200507101/DC1.
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